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Whereas all mammals have one glutamate dehydrogenase gene
(GLUD1), humans and apes carry an additional gene (GLUD2),
which encodes an enzyme with distinct biochemical properties.
We inserted a bacterial artificial chromosome containing the human
GLUD2 gene into mice and analyzed the resulting changes in the
transcriptome andmetabolome during postnatal brain development.
Effects were most pronounced early postnatally, and predominantly
genes involved in neuronal development were affected. Remarkably,
the effects in the transgenic mice partially parallel the transcriptome
and metabolome differences seen between humans and macaques
analyzed. Notably, the introduction of GLUD2 did not affect gluta-
mate levels in mice, consistent with observations in the primates.
Instead, the metabolic effects of GLUD2 center on the tricarboxylic
acid cycle, suggesting that GLUD2 affects carbon flux during early
brain development, possibly supporting lipid biosynthesis.
human evolution | GLUD2 | brain metabolism
Glutamate dehydrogenase (GDH) is a metabolic enzyme cat-alyzing the conversion of glutamate to α-ketoglutarate and
ammonia (1). Whereas the ammonia is metabolized via the urea
cycle, the α-ketoglutarate enters the tricarboxylic acid (TCA)
cycle in mitochondria. Besides its metabolic role, glutamate also
functions as a major excitatory neurotransmitter (2, 3).
Whereas most organisms contain one copy of the GLUD gene
encoding the GDH enzyme, humans and apes have two: GLUD1
and an additional gene, GLUD2, which originated by retroposition
of the GLUD1 transcript after the split from apes and old world
monkeys (4). Sequence analysis suggests that it is highly unlikely
that GLUD2 would have contained an intact ORF and a Ka/Ks <1
throughout the evolution of apes without being functional (5).
Moreover, positive selection has affected GLUD2 (4), including
changes in amino acid residues that make it less sensitive to low pH
and GTP inhibition, and resulting in a requirement for high ADP
levels for allosteric activation (4, 6, 7). GLUD2 mRNA expression
levels in tissues are lower than those of GLUD1, but similarly
distributed across tissues. However, whereas the ancestral version
of the GLUD enzyme occurs both in mitochondria and the cyto-
plasm, GLUD2 is specifically targeted to mitochondria (8, 9).
Changes in GLUD2 properties have been suggested to reflect
functional adaptation to the metabolism of the neurotransmitter
glutamate in the brain (4, 10), and the fact that GLUD2 has been
positively selected and maintained during ape and human evo-
lution suggests that it may have physiological effects important
for the function of ape and human brains. However, the con-
nection between the emergence of the GLUD2 gene in the an-
cestors of apes and humans and changes in brain function
remains elusive. To date, the only direct insights into GLUD2
function come from a rare GLUD2mutation linked to the onset of
Parkinson’s disease (11) and from glioma cells carrying a mutated
isocitrate dehydrogenase 1 gene (IDH1) where GLUD2 expression
reverses the effects of the IDH1 mutation by reactivation of the
metabolic flux from glucose and glutamine to lipids by way of the
TCA cycle (12).
To investigate the physiological role the GLUD2 gene may
play in human and ape brains, we generated mice transgenic for
a genomic region containing humanGLUD2.We compared effects
on gene expression and metabolism during postnatal development
of the frontal cortex of the brain in these mice and their wild-type
littermates, with similar data obtained from humans and rhesus
macaques, the closest relative of humans and apes, which lack the
GLUD2 gene.
Results
A Mouse Model of GLUD2. We constructed transgenic mice carrying
a 176-kb-long human genomic region containing the GLUD2 gene,
as well as 43 kb of upstream and 131 kb of downstream DNA se-
quences (SI Appendix, Fig. S1). To account for effects potentially
caused by stochastic insertion of GLUD2 sequence into the mouse
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genome, we constructed two independent transgenic lines (a and b).
Anatomical, neurophysiological, and behavioral analyses of adult
mice did not reveal any overt effects of theGLUD2 genotype in the
two lines (13).
We assessed the effects of GLUD2 on gene expression and
metabolite concentrations in the developing frontal cortex of
hemizygous (GLUD2+) mice from both lines as well as control
littermates, using RNA sequencing (RNA-seq) and capillary
electrophoresis coupled with mass spectrometry (CE-MS). RNA-
seq data were collected from 30 GLUD2+ and 29 control individ-
uals. Metabolite concentrations were measured in 56GLUD2+ and
81 control individuals. The mice varied in age from 3 d to 18 mo,
with ages and sexes matched between transgenic and control
groups (Fig. 1 A and B and SI Appendix, Table S1).
To assess whether molecular changes induced by GLUD2 in
the mice might recapitulate differences between hominoids (apes
and humans) and other primates, we measured metabolite concen-
trations in prefrontal cortex of 35 humans and 31 rhesus macaques
using CE-MS. For both species, samples covered the respective
lifespans approximately corresponding to the one sampled in the
mice: from 16 d postnatal to 90 y in humans, and from 18.4 wk
postconception to 21 y in macaques (Fig. 1B and SI Appendix, Table
S2). We furthermore analyzed RNA-seq data previously collected in
the prefrontal cortex of 38 humans and 40 rhesus macaques covering
the same age span (14) (Fig. 1A and SI Appendix, Table S2).
Between these two datasets, 13 human and 20 macaque indi-
viduals overlapped for both the RNA-seq and CE-MS data (SI
Appendix, Table S2).
GLUD2 Affects Gene Expression During Early Postnatal Development.
Based on 613 million, 100 nt-long sequence reads collected from
the mouse polyA-plus RNA (SI Appendix, Table S3), we detected
expression of 18,610 protein-coding and noncoding genes. Global
expression variation among the samples showed a clear effect
of age when analyzed by principal component analysis (PCA),
whereas neither genotype nor sex affected gene expression sub-
stantially (Fig. 2A and SI Appendix, Fig. S2). Consistently, as many
as 15,663 of the 18,610 detected genes, including the GLUD2
transgene, showed significant age-dependent expression changes in
the mouse cortex [F-test, Benjamini–Hochberg (BH) corrected
P < 0.05, false discovery rate (FDR) < 0.01].
Both transgenic mouse lines showed the same developmental
expression profile ofGLUD2, which was distinct from the expression
profile of GLUD1 (SI Appendix, Fig. S3). Notably, the GLUD2 ex-
pression trajectory in the developing mouse brain strongly resem-
bled the trajectory of GLUD2 expression during prefrontal cortex
development in humans (Pearson correlation, r = 0.86, P < 0.0001; SI
Appendix, Fig. S4). We also detected expression of a long noncoding
RNA (lncRNA) originating from the opposite strand of the trans-
fected human genomic region upstream of the GLUD2 transcription
start site (SI Appendix, Fig. S5). Expression profile of this lncRNA
closely resembled the expression profile ofGLUD2 (SI Appendix, Fig.
S6), suggesting that it is expressed from the same bidirectional pro-
moter as GLUD2 (SI Appendix, Table S4).
An effect of the GLUD2 genotype, albeit small, was de-
tectable: using analysis of covariance (ANCOVA) with linear,
quadratic, and cubic models, we identified 12 protein-coding
genes and one lncRNA showing significant expression differ-
ences between the two transgenic lines and control littermates
(F-test, BH corrected P < 0.05, permutations P < 0.05, FDR <
0.01, SI Appendix, Table S5). Strikingly, the effect of the
GLUD2 genotype was observed only during early postnatal
development and disappeared at approximately 2 wk of age
(Fig. 2B). By contrast, other genes expressed in the mouse
brain did not show any increased divergence between trans-
genic and control mice during early development (Fig. 2C).
Eleven of the 13 genes differentially expressed between trans-
genic and control mice fell into the same coexpressed module in
an unsupervised hierarchical clustering analysis (Fig. 3A and SI
Appendix, Table S5 and Fig. S7), an observation not expected by
chance (permutations, P < 0.001) (SI Appendix, Fig. S8). The
genes affected by GLUD2 are thus coexpressed during mouse
development. The expression of these 11 genes decreased rapidly
during early postnatal development in both transgenic and control
mice, but in the transgenic mice, the decrease in expression was
shifted to earlier stages of development (Fig. 3 B and C and SI
Appendix, Fig. S9).
Based on analysis of Gene Ontology (GO) terms (15), the
11 coexpressed genes were significantly enriched in several
biological processes, many of them related to neural devel-
opment and transcriptional regulation (hypergeometric test,
FDR corrected P < 0.05) (Fig. 3D and SI Appendix, Table S6), a
result robust to the use of different background gene distributions.
The genes affected by GLUD2 may thus to some extent be func-
tionally related.
GLUD2 Effects in the Mice Mirror Differences Between Primates. To
assess whether the effect of GLUD2 in the mice recapitulated
differences between primate species that lack and that have
GLUD2, we reanalyzed 579 million, 100-nt-long RNA-seq reads
from the prefrontal cortex of rhesus macaques and humans. We
detected the expression of 23,115 protein-coding and noncoding
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Fig. 1. Sample information. (A) Schematic representation of age, sex, and
transgenic line information for mouse and primate samples used for tran-
scriptome (RNA-seq) measurements. (B) Schematic representation of age, sex,
and transgenic line information for mouse and primate samples used for
metabolome (CE-MS) measurements. Each symbol represents an individual
sample. The colors indicate genotype/species information: orange, transgenic
mice; green, control mice; red, humans; blue, rhesus macaques. Lighter shades
of color indicate younger ages. The bars show the corresponding age intervals:
d, days; y, years. The symbols indicate mice lines: circles, line a; triangles, line b.
Filled symbols indicate males; empty symbols indicate females.
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Fig. 2. Effect of the GLUD2 genotype on gene expression in the mouse
model. (A) The first two principal components (PCs) of the principal com-
ponent analysis, based on the expression of 18,610 genes detected in the
mouse brain. Each circle represents an individual. The colors indicate geno-
type information: orange, transgenic mice; green, control mice. Symbols
filled by lighter shades of color indicate younger ages. (B) The mean nor-
malized gene expression divergence between transgenic and control mice,
based on the 13 age-dependent genes with expression affected by the
GLUD2 genotype (red curve). The colored area shows variation of the di-
vergence estimates obtained by bootstrapping the 13 genes 1,000 times.
(C) The mean normalized gene expression divergence between transgenic
and control mice, based on the remaining 15,650 age-dependent genes
(light-red curve). The colored area shows variation of the divergence esti-
mates obtained by subsampling 13 genes 1,000 times.
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genes. PCA analysis of the expression of these genes demon-
strated substantial species-dependent as well as age-dependent
divergence (Fig. 4A).
Among the 13 genes differentially expressed between trans-
genic and control mice, 9 were expressed in human and macaque
prefrontal cortex (SI Appendix, Table S5). Remarkably, the ex-
pression of these 9 genes showed a large divergence between
humans and macaques at the earliest stages of postnatal devel-
opment after which the divergence rapidly decreased. Thus, the
expression differences between humans and macaques re-
sembled those seen between mice carrying a GLUD2 gene and
control littermates (Fig. 4B). By contrast, other genes expressed
in human and macaque prefrontal cortex showed no such di-
vergence pattern (permutation P = 0.05, Fig. 4C).
Furthermore, seven of the nine genes showed a rapid expression
level decrease during human and macaque early postnatal devel-
opment, i.e., the same developmental expression trajectory as the
genes affected by GLUD2 in the transgenic mice (Pearson correla-
tion, r > 0.9, permutation P < 0.001, SI Appendix, Figs. S10 and S11).
After adjusting for the differences in lifespan between humans and
macaques, we found a shift in the timing of the expression to earlier
developmental stages in humans relative to macaques (Fig. 4D and
SI Appendix, Fig. S10), similar to what is seen in the GLUD2 mice.
This was not caused by any general mismatching of human and
macaque developmental timing, as other genes did not show such a
coordinated shift to earlier developmental stages (Pearson correla-
tion, r > 0.9, permutation P = 0.02, SI Appendix, Fig. S12). Thus,
gene expression changes in GLUD2 mice indeed recapitulate gene
expression differences between human and macaque expression
profiles during early postnatal development.
Among the 7 genes showing similar expression and developmental
shifts in the transgenic mice and in human cortex, 3 are transcription
factors (TFs) implicated in neural development: SRY (sex de-
termining region Y)-box 4 (SOX4), SRY (sex determining region Y)-
box 11 (SOX11), and Distal-less homeobox 2 (DLX2) (16–22). A
total of 15 known neural-related target genes of these TFs (16–29)
were expressed in the mice and 14 in the primates (SI Appendix,
Table S7). The expression divergence profiles of these target genes
and the corresponding TFs between the transgenic and control
mice and between humans and macaques at different ages were
significantly correlated (Pearson correlation, r > 0.5; permuta-
tion P = 0.008 for mice and P = 0.001 for primates, SI Appendix,
Fig. S13), suggesting that the effects of GLUD2 may go beyond
the 13 genes showing differences between the transgenic and
control mice.
As the effects of GLUD2 in the mice were strongest at the
earliest stages of postnatal development, it is possible that GLUD2
plays a role mainly in prenatal development. To test if this may be
the case in humans, we analyzed the expression of the 13 genes
affected by GLUD2 expression in the mice using RNA-seq data
from prenatal prefrontal cortex development of humans (30) and
macaques. Of the 13 genes, 9 had detectable expression in our
human and macaque data, as well as in public fetal human cortex
data. Strikingly, expression of the 9 genes was substantially more
divergent between humans and macaques before than after birth
(Fig. 5 A and B and SI Appendix, Fig. S14), whereas other
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Fig. 4. Gene expression in primates. (A) The first and third PCs of the principal
component analysis, based on the expression of 23,115 genes detected in human
and rhesus macaque prefrontal cortex. Each circle represents an individual (red,
humans; blue, macaques). Lighter shades of color indicate younger ages. (B) The
mean normalized gene expression divergence between humans and macaques
based on the 9 genes with expression affected by GLUD2 genotype in the mouse
model (red curve). The colored area shows variation of the divergence estimates
obtained by bootstrapping the 9 genes 1,000 times. “H-birth” x-axis marks rep-
resent human birth age. (C) The mean normalized gene expression divergence
between humans and macaques based on the remaining 23,106 detected genes
(light-red curve). The colored area shows variation of the divergence estimates
obtained by subsampling 9 genes 1,000 times. (D) Expression profiles of E2F
transcription factor 7 (E2F7), SOX11, and SOX4, which are among the 7 genes
showing the similar expression and divergence pattern in primates and the
transgenic mice. Each point represents an individual. The colors indicate species
information: red, humans; blue, macaques. Filled symbols indicate postnatal ages;
empty points, prenatal ages. The vertical dashed line shows the human birth age.
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Fig. 3. Patterns and functions of genes with expression affected by GLUD2
genotype. (A) Dendrogram based on unsupervised hierarchical clustering of
15,663 age-dependent genes. The colors represent coexpressed modules. The
darker shades of color indicate larger modules. Dashed green rectangle shows
module 1 containing 11 of the 13 genes with expression affected by the GLUD2
genotype. (B) Expression profiles of 3 of the 11 module 1 genes with expression
affected by the GLUD2 genotype. Each point represents an individual sample. The
colors indicate genotype information: orange, transgenic mice; green, control mice.
The symbols indicate mice lines: circles, line a; triangles, line b. The lines show spline
curves fitted to expression data points with four degrees of freedom. (C) De-
velopmental time shift between transgenic mice and control mice, calculated based
on expression of 11 module 1 genes with expression affected by the GLUD2 ge-
notype (dark-red curve) and the remaining 15,652 age-dependent genes (light-red
curve). The light-red–colored area shows variation of time-shift estimates for the
remaining age-dependent genes, obtained by randomly subsampling 11
genes 1,000 times. The curves are obtained by aligning transgenic mice
expression time series to that of control mice, using the modified dynamic
time warping algorithm, showing the ages where transgenic mice expression
levels correspond to those of control mice. During early stages of develop-
ment, transgenic mice ages are mapped to older ages in control mice, in-
dicating transgenic mice expression profiles shift to earlier developmental
stages. (D) GO biological processes significantly enriched in 11 module-1
genes with expression affected by the GLUD2 genotype. Biological processes
related to neural development are shown in bold.
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expressed genes showed no obvious increase in expression dif-
ferences before birth (Fig. 5C).
Brain Metabolism in GLUD2 Mice and Primates. We assessed the
effects of GLUD2 on metabolism in the brains of the GLUD2
mice using CE-MS. For comparisons, we similarly analyzed hu-
man and macaque brains. We detected and quantified 110 and
88 metabolites in the mice and in humans and macaques, re-
spectively (SI Appendix, Tables S8 and S9). PCA analysis based
on concentration levels of these metabolites revealed a sub-
stantial effect of age in both mice and primates (Fig. 6 A and B).
We first focused on the concentration levels of glutamate, the
direct substrate of the GDH2 enzyme encoded by GLUD2. We
detected no effect of GLUD2 on glutamate concentration in the
mouse cortex (Fig. 6C). By contrast, glutamate concentrations in
the prefrontal cortex of the humans are substantially lower than
in the macaques (Fig. 6C). Previous work using gas chromatography
coupled with mass spectrometry (GC-MS) has shown that compared
with humans, chimpanzees as well as macaques have higher gluta-
mate levels in the brain (31), something that reexamination of the
published glutamate data confirms (Fig. 6C). Because both humans
and chimpanzees carry GLUD2 genes, a mechanism other than the
mere presence of GLUD2 must be responsible for the lower gluta-
mate concentrations in the human brain.
Despite the absence of a GLUD2 effect on glutamate levels in
the mice, we detected that the overall differences between the
metabolomes of the transgenic and the control mice were about
threefold larger shortly after birth relative to 2 mo after birth (SI
Appendix, Fig. S15). To test if this may be at least partially con-
nected to gene expression differences, we compared the concen-
tration profiles of 24 metabolites associated with the metabolic
pathways where the 13 genes differentially expressed between
transgenic and control mice are located (SI Appendix, Table S8).
Concentration differences of the 24 metabolites were substantially
larger than the differences for the 86 remaining compounds
analyzed (Fig. 7A). Similar results were obtained using the Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway anno-
tation and the Small Molecule Pathway Database (32) to identify
metabolites and pathways associated with the 13 genes (SI Ap-
pendix, Fig. S16).
The 13 genes and 24 metabolites showing increased divergence
between the transgenic and control mice converged within seven
KEGG pathways (SI Appendix, Table S10). For three of these
pathways, the HIF-1 signaling pathway, the pentose phosphate
pathway, and carbon metabolism, metabolite concentration dif-
ferences were significantly greater than expected by chance
(permutations, P < 0.05) (Fig. 8A). The three pathways are
closely related as the “carbon metabolism” pathway includes the
pentose phosphate pathway and the TCA cycle, which is in turn
linked to the HIF-1 signaling pathway (Fig. 8B).
We next analyzed metabolic differences between human and
macaque brains. As the human samples were frozen after sub-
stantial postmortem delay (PMD), we first analyzed the effects of
PMD by comparing three macaque samples that were intentionally
collected with substantial PMD with macaque samples that were
not (SI Appendix, Table S11). Of the 88 metabolites detected in the
macaque and human brains, 21 were affected by PMD in at least
one of the three samples analyzed (SI Appendix, Fig. S17 and Table
S9) and were therefore excluded from further analyses.
For the remaining 67 metabolites, the differences between
humans and macaques explained 26% of the total variation in
metabolite concentrations. By comparison, theGLUD2 genotype
explains 2% of the metabolic variation in the mice (SI Appendix,
Fig. S18). Despite the much greater overall metabolic differences
between macaques and humans than between the transgenic and
control mice, it is notable that in both cases, the greatest meta-
bolic differences are seen in early development (SI Appendix,
Figs. S15 and S19).
Of the 24 metabolites linked to the genes differentially
expressed between GLUD2 and control mice, 11 were among the
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Fig. 5. Prenatal gene expression. (A) Prenatal expression profiles of E2F7,
SOX11, and SOX4 genes, which are among the 7 genes showing similar ex-
pression and divergence patterns in primates and the transgenic mice. Each
point represents an individual. The colors indicate species information: red,
humans; blue, macaques. Filled symbols indicate postnatal ages; empty
points, prenatal ages (17 in humans and 4 in macaques). The vertical dashed
line shows the human birth age; pcw, weeks postconception. (B) The mean
normalized gene expression divergence between humans and macaques
based on the 9 genes with expression affected by the GLUD2 genotype,
calculated using a published fetal human dataset (red curve). The colored
area shows variation of the divergence estimates obtained by bootstrapping
the 9 genes 1,000 times. (C) The mean normalized gene expression di-
vergence between humans and macaques, based on the remaining 15,897
detected genes in the public fetal human and our macaque time series data
(light-red curve). The colored area shows variation of the divergence esti-
mates obtained by subsampling 9 genes 1,000 times.
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67 metabolites that were detected and unaffected by PMD in
humans and rhesus macaques (SI Appendix, Table S9). As in the
mice, these 11 metabolites diverged more between humans and
macaques than the other detected metabolites in early devel-
opment (Fig. 7B). However, this effect was less pronounced in
development and also apparent at later age, possibly due to
fewer metabolites detected in the primates than in the mice, as
well as differences in lifespan. Still, for 8 of the 11 metabolites
detected in both primates and mice, the direction of concen-
tration change coincided between humans and transgenic mice
(permutation, P = 0.08) (SI Appendix, Fig. S20). Thus, GLUD2
transgenic mice recapitulate some of the metabolic differences
seen between human and macaque brains.
Discussion
GLUD2 originated as an evolutionary novel version of the glutamate
dehydrogenase gene as a result of the retroposition of a GLUD1
transcript in the common ancestors of humans and apes. We in-
vestigated the function of GLUD2 by inserting the human GLUD2
gene and surrounding sequences carrying putative regulatory ele-
ments into the mouse genome. We isolated two independent
transgenic lines to exclude artifacts caused by the insertion of the
human gene in the mouse genome. When analyzed in the frontal
cortex, both lines displayed similar developmental GLUD2 expres-
sion trajectories, closely resembling GLUD2 expression in human
prefrontal cortex during development.
In both transgenic lines, GLUD2 affects the expression of 13
genes, 11 of which show similar ontogenetic expression pro-
files. These genes include several TFs, among which DLX2, SOX4,
and SOX11 play important roles in neuronal differentiation and
neurogenesis (16, 18, 19, 25). Some of the previously described
targets of these TFs show changes in expression in the transgenic
mice that are correlated with expression changes of the corre-
sponding TFs. Nine primate orthologs of the 13 mouse genes
affected by GLUD2, including DLX2, SOX4, and SOX11, differ
in expression between human and macaque ontogenesis in ways
that mirror the changes seen in the mice. Similarly, primate
orthologs of target genes of DLX2, SOX4, and SOX11 show ex-
pression differences correlating with those of these TFs. These
results illustrate that the introduction of GLUD2 into the mouse
genome induces effects paralleling evolutionary differences
between primate species that carry a GLUD2 gene and those
that do not. This adds to a mounting amount of evidence sug-
gesting that human-specific variants of genes such as FOXP2,
ASPM, EDAR, SRGAP2, and CMAH can be fruitfully studied in
mouse models (33).
The gene expression changes induced by GLUD2 in the mice
and the differences between humans and macaques were re-
stricted to early development and were not observed past the
first 2 wk postpartum in the mice or the first 2 y of life in humans.
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Fig. 7. Metabolome analyses of transgenic mice and primates. (A) The
mean normalized metabolite concentration divergence between trans-
genic and control mice, based on the 24 metabolites sharing the same
KEGG pathway as the 13 genes with expression affected by the GLUD2
genotype (dark-blue curve) and the remaining 86 detected metabolites
(light-blue curve). The colored area shows variation of the divergence
estimates of the 86 metabolites obtained by bootstrapping 1,000 times.
(B) The mean normalized metabolite concentration divergence between
humans and macaques based on 11 of the 24 metabolites linked to the
GLUD2 genotype effect in mice (dark-blue curve) and the remaining 56
detected metabolites (light-blue curve). The colored area shows variation
of the divergence estimates of the 56 metabolites obtained by boot-
strapping 1,000 times.
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Fig. 8. Pathway analysis of the GLUD2 genotype effect on mouse metab-
olome. (A) Metabolite concentration divergence between transgenic and
control mice, based on metabolites in a pathway (red circles). The boxplots
show metabolite concentration divergence between transgenic and control
mice, calculated by sampling 1,000 times the same number of metabolites as
detected in a given pathway from the bulk of remaining detected metabolites.
Each pathway contains at least two detected metabolites and at least one gene
differentially expressed between transgenic and control mice. The filled circles
show the pathways with significantly greater metabolic divergence than expected
by chance. (B) The schematic representation of the three KEGG pathways showing
significantly greater metabolite concentration divergence between transgenic
and control mice: HIF-1 signaling pathway, pentose phosphate pathway, and
carbon metabolism. Detected metabolites are shown in blue and genes with
expression affected by the GLUD2 genotype are shown in red. Dashed pink
rectangle delineates the pathway affected by GLUD2 overexpression in IDH1-
mutant glioma cells.
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This suggests that GLUD2 mainly functions during brain growth
and early development, a notion that is in apparent contradiction
to the idea that GLUD2 has a major role in the metabolism of
the neurotransmitter glutamate.
The metabolic data lend support to the notion that GLUD2
mainly influences aspects of metabolism different from glutamate
recycling. We detect no effects on glutamate concentrations in the
mouse frontal cortex and our previous results show that glutamate
concentrations do not differ between macaques and chimpanzees
throughout prefrontal cortex developmental and adult stages,
even though chimpanzees carry a GLUD2 gene. Instead, meta-
bolic differences between GLUD2+ and control mice center on
the metabolic pathways surrounding the TCA cycle. In agreement
with this, it has been reported that overexpression of human
GLUD2, but not GLUD1, in mutant murine glioma progenitor
cells results in shunting of carbon into lipid biosynthesis via the
TCA cycle (12). Our data further show that metabolic differences
between GLUD2+ and control mice, as well as between humans
and macaques, are particularly prevalent at early developmental
stages characterized by rapid brain growth. Given that lipids
comprise more than 50% of the brain’s dry weight (34), we
speculate that GLUD2 may support the rapid growth of the large
ape and human brains by enhancing lipid biosynthesis.
Materials and Methods
A detailed description of materials and methods is provided in SI Appendix.
Briefly, a human bacterial artificial chromosome containing the GLUD2 gene
(RP11-610G22) was linearized by NotI and injected into the male pronucleus
of C57BL/6 mice to construct GLUD2+/− transgenic mice. Transgenic animals
were identified by PCRs targeting the 5′-end, the coding region, and the
3′-end of the gene. For metabolome analysis, CE-MS measurements were
conducted in frontal cortex samples of 81 control and 56 transgenic mice
and prefrontal cortex samples of 35 humans and 34 rhesus macaques.
Transcriptome analysis was conducted in the frontal cortex of 29 control and
30 transgenic mice used for metabolite profiling on the Illumina platform, as
well as in prefrontal cortex of 38 humans and 40 rhesus macaques (14).
Written consent for the use of human tissues for research was obtained from
all donors or their next of kin. Use of human autopsy tissue is considered
nonhuman subject research and is institutional review board exempt under
NIH guidelines. Biomedical Research Ethics Committee of Shanghai Institutes
for Biological Sciences completed the review of the use and care of the
animals in the research project (approval ID: ER-SIBS-260802P).
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